Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

doi:10.1128/AAC.42.9.2184

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Antimicrobial agents and chemotherapy - 1 Sept 1998

Sirot D, Labia R, Pouedras P, Chanal-Claris C, Cerceau C, Sirot J

Abstract excerpt

Klebsiella oxytoca strains are generally moderately resistant to amoxicillin and ticarcillin due to the activities of the chromosomally encoded OXY-1 and OXY-2 class A beta-lactamase families. These enzymes have the ability to hydrolyze not only penicillins but also cephalosporins, including cefuroxime, ceftriaxone, and aztreonam, and are inhibited by clavulanic acid. A Klebsiella oxytoca strain was isolated from...

Topics

Drug Resistance, Microbial
Isoelectric Focusing
Klebsiella
Phenotype
beta-Lactamase Inhibitors
beta-Lactamases

Source

Open in PubMed Open full text

Identifiers

PMID: 9736532
DOI: 10.1128/AAC.42.9.2184
PMCID: PMC105771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics